Dabigatran acyl-β-D-glucuronide-d₃ TFA 

Dabigatran acyl-β-D-glucuronide-d₃ (TFA) is the deuterium labeled Dabigatran Acyl-β-D-Glucuronide trifluoroacetate[1].

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

762.70

C₃₄H₃₃D₃F₃N₇O₁₀

1015167-40-4

OC([C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1OC(CCN(C2=CC=CC=N2)C(C3=CC=C(C(N=C4CNC5=CC=C(C=C5)C(N)=N)=C3)N4C([2H])([2H])[2H])=O)=O)=O.CC(C(F)(F)F)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.  [Content Brief]